Johnson & Johnson shares rise after talc settlement offer
Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.
Stay updated with breaking news from Lee Hambright. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.
Wall Street analysts were encouraged by J&J’s proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.
The collapse of the cryptocurrency market in the past few months has highlighted the perils of investing in speculative assets, especially to retail investors or beginners who had only just begun their...
DexCom, Inc. (NASDAQ:DXCM), a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems.
In this article, we discuss 10 dividend stock picks of legendary value investor Joel Greenblatt.